Yamashita, S., Masuda, D., & Matsuzawa, Y. (2020). Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases. Curr Atheroscler Rep.
Chicago ZitierstilYamashita, Shizuya, Daisaku Masuda, und Yuji Matsuzawa. "Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases." Curr Atheroscler Rep 2020.
MLA ZitierstilYamashita, Shizuya, Daisaku Masuda, und Yuji Matsuzawa. "Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases." Curr Atheroscler Rep 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.